Skip to content

Powdered Intrawound Vancomycin in Open Fractures Trial

Powdered Intrawound Vancomycin in Open Fractures: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06504992
Acronym
PIVOT
Enrollment
350
Registered
2024-07-17
Start date
2024-11-01
Completion date
2029-09-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures, Bone, Fractures, Open, Infection, Surgical Site, Open Fracture, Post-Operative Wound Infection, Trauma, Wound Infection

Keywords

open fracture, vancomycin, infection, trauma, intrawound

Brief summary

The purpose of this randomized control trial is to compare the rate of post-operative infection in patients with open fractures in upper or lower extremity long bones randomized to receive intra-operative intrawound topical vancomycin powder on their open fractures in addition to the current best practice of intravenous antibiotics with irrigation and debridement compared to intravenous antibiotics with irrigation and debridement alone during definitive operative fixation of the fracture.

Detailed description

Primary Objective: To evaluate the effect of intra-operative intrawound topical vancomycin powder on open fractures in addition to the current best practice of intravenous antibiotics with irrigation and debridement compared to intravenous antibiotics with irrigation and debridement alone during definitive fixation of the fracture on deep surgical site infection, defined as a post-operative surgical infection requiring return to the operating room for irrigation and debridement with or without hardware removal/revision within the first six months following surgery. Secondary Objectives: To evaluate the effect of intra-operative intrawound topical vancomycin powder on superficial surgical site infection, defined as a post-operative infection that required antibiotic treatment but no return to the operating room, readmissions to hospital for post-operative surgical infection (deep or superficial), and hardware failure, defined as hardware loosening, loss of fixation, hardware fracture, or hardware migration, visualized either on imaging or found intra-operatively. To evaluate differences in microbe characteristics in cultures taken intra-operatively in the take-back irrigation and debridement surgery in patients with deep surgical site infection. To evaluate if the effect of intra-operative intrawound topical vancomycin powder changes based on fracture and patient characteristics: upper extremity versus lower extremity, Gustilo Classification, patients with documented Methicillin-resistant Staphylococcus aureus (MRSA) colonization, and mechanism of injury. To evaluate if certain fracture and patient characteristics: upper extremity versus lower extremity, Gustilo Classification, patients with documented Methicillin-resistant Staphylococcus aureus (MRSA) colonization, and by their mechanism of injury increases the risk of infection in both the treatment and control group.

Interventions

Powdered, intrawound vancomycin 1000 mg at the time of definitive surgery for open fracture fixation in addition to the current best practice of intravenous antibiotics with irrigation and debridement

Sponsors

Health Sciences Centre, Winnipeg, Manitoba
CollaboratorOTHER
University of Manitoba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

The study is a randomized controlled trial blinded to participants and end-point assessors. Participants will be randomized to either receiving the treatment, intra-operative intrawound topical vancomycin powder on open fractures in addition to intravenous antibiotics with irrigation and debridement, or the control, intravenous antibiotics with irrigation and debridement alone.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older at time of surgery * Patients with an open fracture classified as Gustilo Type I to IIIc in the clavicle, humerus, radius, ulna, metacarpals, upper extremity phalanges (fingers), femur, tibia, fibula and metatarsals and lower extremity phalanges (toes). * Open fracture treated operatively with plate(s) and screw(s) hardware fixation and intramedullary fixation (IM nail). * Able to attend standard of care follow up for six months post-operatively

Exclusion criteria

* Patients with known vancomycin allergy, drug administration reaction, or other sensitivities to vancomycin. * Patients who have already had definitive fracture fixation before enrollment in the study * Patients with open fracture already infected at time of enrollment * Patients with current positive blood cultures (bacteremia) at time of enrollment (current, meaning they have not received treatment and now have negative most-recent blood cultures). * Patients who have other forms of local antibiotics that are left in place at the end of the definitive fixation surgery (e.g., antibiotic loaded cement or polymethyl methacrylate (PMMA) beads) * Patients who do not speak English * Patients who are currently pregnant * Patients who are unable to provide consent and do not have a substitute decision maker able to provide consent * Patients who will have severe difficulty with follow up

Design outcomes

Primary

MeasureTime frameDescription
Deep surgical site infectionWithin six months of definitive surgical orthopedic fixationA post-operative surgical infection requiring return to the operating room for irrigation and debridement with or without hardware removal/revision after the definitive fixation.

Secondary

MeasureTime frameDescription
Hardware failure visualized either on imaging or found intra-operatively, until six months post definitive fixationUp until six months following definitive fixationHardware loosening, loss of fixation, hardware fracture, or hardware migration visualized either on imaging or found intra-operatively
Microbe sensitivityUp until six months following definitive fixationIn patients with deep surgical site infection, the gram stain and sensitivity and resistance to antibiotics of cultures taken intra-operatively in the take-back irrigation and debridement surgery
Fracture locationAt time of initial open fractureWhether the fracture is in the upper extremity: clavicle, humerus, radius, ulna, metacarpals and phalanges (fingers) versus lower extremity: femur, tibia, fibula, metatarsals, and phalanges (toes).
Superficial surgical site infectionWithin six months of definitive surgical orthopedic fixationA post-operative infection that required antibiotic treatment but no return to the operating room
Mechanism of injuryAt time of initial open fractureMechanism of injury will be categorized as: i. Motor vehicle collision: car occupant, pedestrian, motorcyclist, other ii. Other Vehicle Accident: all-terrain vehicle (ATV), bicycle, snowmobile iii. Fall: from own height (slip/stumble), from height less than or equal to 3 metres, from height greater than 3 metres iv. Laceration v. Striking with blunt object (unintentional) vi. Crush injury vii. Sport related injury viii. Interpersonal violence: stabbing, striking with sharp object (e.g., machete), striking with blunt object, gunshot, other
MRSA colonizationDuring initial admission to hospital for open fractureNasal swab for MRSA that is routinely taken for all patients admitted to the study's hospital
Fracture Gustilo ClassificationAt time of definitive surgical orthopedic fixation.Open fracture classification from Type I to IIIc that classifies open fractures based on extent of bone, soft tissue and vascular injuries.

Countries

Canada

Contacts

Primary ContactGabriel Larose, MD, MSc, FRCSC
glarose@hsc.mb.ca2047872261
Backup ContactMadison Price, MD
pricem@myumanitoba.ca

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026